These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 960050)

  • 1. A simplified method for isolation of the S-carboxymethyl derivative chains of normal fibrinogen and fibrinogen Cleveland and I.
    Forman WB; Hadady M
    Thromb Res; 1976 Jun; 8(6):731-6. PubMed ID: 960050
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
    Southan C; Kehl M; Henschen A; Lane DA
    Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the degradation of fibrinogen Giessen I.
    Bleyl H; Krause WH
    Thromb Res; 1976 Oct; 9(4):329-34. PubMed ID: 136059
    [No Abstract]   [Full Text] [Related]  

  • 5. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():15-7. PubMed ID: 796805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.
    Weinstein MJ; Deykin D
    Thromb Res; 1978 Sep; 13(3):361-77. PubMed ID: 741433
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of an abnormal fibrinogen by two-dimensional electrophoresis.
    Polack B; Valiron O; Concord E; Freyssinet JM; Hudry-Clergeon G
    Clin Chem; 1984 Dec; 30(12 Pt 1):2093-7. PubMed ID: 6499181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deficiency in A alpha chain's N-terminal alanine residue as a major cause of the slow coagulation of fetal fibrinogen.
    Hasegawa N; Sasaki S
    Thromb Res; 1989 Jun; 54(6):595-602. PubMed ID: 2571197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I).
    Budzynski AZ; Marder VJ; Ménaché D; Guillin MC
    Nature; 1974 Nov; 252(5478):66-8. PubMed ID: 4427684
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved method for the preparative isolation of the S-carboxymethyl derivative chains of human fibrinogen.
    Murano G; Williams L
    Prep Biochem; 1974; 4(1):1-12. PubMed ID: 4836087
    [No Abstract]   [Full Text] [Related]  

  • 17. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of three gamma-chains with different molecular weights from normal human plasma fibrinogen.
    Francis CW; Keele EM; Marder VJ
    Biochim Biophys Acta; 1984 Mar; 797(3):328-35. PubMed ID: 6696949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis.
    Budzynski AZ; Marder VJ; Shainoff JR
    J Biol Chem; 1974 Apr; 249(7):2294-302. PubMed ID: 4131967
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.